Edition:
India

Kitov Pharmaceuticals Holdings Ltd (KTOV.OQ)

KTOV.OQ on NASDAQ Stock Exchange Capital Market

2.04USD
10:26pm IST
Change (% chg)

$0.01 (+0.49%)
Prev Close
$2.03
Open
$2.03
Day's High
$2.04
Day's Low
$2.01
Volume
12,149
Avg. Vol
68,136
52-wk High
$3.49
52-wk Low
$1.27

Summary

Name Age Since Current Position

John Waymack

63 2013 Chairman of the Board & Chief Medical Officer

Itzhak Israel

37 2012 Chief Executive Officer, Director

Simcha Rock

65 2013 Chief Financial Officer, Director

Gil Ben-Menachem

2016 Vice President - Business Development

Yisrael Gewirtz

40 2016 Internal Auditor

Ido Agmon

39 2016 Director

Steven Steinberg

55 2016 Director

Arie Weber

68 2017 Director

Alain Zeitoun

55 2013 External Director

Philip Serlin

56 2013 Independent Director

Revital Stern-Raff

43 2017 Independent Director

Biographies

Name Description

John Waymack

Dr. John Paul Waymack serves as Chairman of the Board and Chief Medical Officer at Kitov Pharmaceuticals Holdings Ltd since July 11, 2013. Dr. Waymack has over 20 years of experience in the bio-pharma field. Dr. Waymack is a former academic transplant surgeon and a former FDA medical officer, with over 15 years of experience in drug development as a consultant to major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10 years of academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. In addition, Dr. Waymack volunteered to the U.S. army, where he was commissioned and served as a Major in the Medical Corp. in the position of Chief of Surgical Research in the U.S. Army’s Institute for Surgical Research. Dr. Waymack was also an associate professor of surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey.

Itzhak Israel

Mr. Itzhak Israel serves as Chief Executive Officer and Director at Kitov Pharmaceuticals Holdings Ltd since October 31, 2012. Mr. Israel's work experience includes the following roles: Director at Ducant Connecting To Medicine Ltd, Uneri Capital Ltd, Lithotec Medical Ltd, Nextgen Biomed Ltd, Dermipsor Ltd, and at Ofakim Ventures Ltd., Founder and Chief Executive Officer of B Contact Communication, Vice President-Business Development at Ofakim Ventures Ltd and Meytag Hi-Tech Ventures Ltd, and Chief Executive Officer of Dermipsor Ltd, Einspein Medical Ltd.

Simcha Rock

Mr. Simcha Rock serves as Chief Financial Officer and Director at Kitov Pharmaceuticals Holdings Ltd since July 11, 2013. Mr. Rock was a private equity manager at Edmond de Rothschild Private Equity Management (February 2000-January 2011), a firm specializing in the management of venture capital and other private equity investments funds, with responsibility for all financial, legal and administrative matters for several investment funds. Prior to 2000, Mr. Rock held financial management positions at Intel Electronics Ltd., The Jerusalem College of Technology, and JC Technologies Ltd. Mr. Rock holds a BA from Yeshiva University and an MBA from Cleveland State University.

Gil Ben-Menachem

Dr. Gil Ben-Menachem has been appointed Vice President - Business Development at Kitov Pharmaceuticals Holdings Ltd effective January 8, 2016. Dr. Ben-Menachem is a life sciences business development executive with over 12 years experience in the pharmaceutical, biotechnology and venture capital industries. His work experience includes the following roles: Head of Innovative Products at Dexcel Pharma, Business Development Director at Teva Pharmaceutical Industries, Chief Executive Officer at OphthaliX and Director of Business Development at Paramount Biosciences. He holds the following degrees: a Bachelor of Science degree in Biology, a Master of Science degree in Biotechnology and a Doctorate of Science degree in Microbiology, all from The Hebrew University of Jerusalem and a MBA degree from University of Maryland.

Yisrael Gewirtz

Mr. Yisrael Gewirtz has been appointed Internal Auditor at Kitov Pharmaceuticals Holdings Ltd. effective July 13, 2016. His work experience includes the role of Partner in a private Accountancy firm for over five years. Mr. Gewirtz holds a Bachelors degree in Accounting and Economics from Bar Ilan University. He is a Certified Chartered Accountant.

Ido Agmon

Mr. Ido Agmon has been appointed Director at Kitov Pharmaceuticals Holdings Ltd effective June 26, 2016. His work experience includes the following roles: Manager and C-Founder of Aviv New-Tech, Independent Consultant-strategic planning and fund-raising (from 2012), Chief Executive Officer at Meytav Technology Incubator (2009-2011) and Director of Business Development in ATI Incubator (2007-2009). He holds a Bachelor of Business Administration degree and a Bachelor of Science degree in Life Sciences from Tel Aviv University and a MBA degree from The Hebrew University of Jerusalem.

Steven Steinberg

Mr. Steven Steinberg has been appointed Director at Kitov Pharmaceuticals Holdings Ltd. effective July 13, 2016. His work experience includes the following roles: Chief Financial Officer of Glide Talk Ltd. (from January 2015), Vice President-Finance at ClientConnect Ltd. ( September 2013-October 2014), Independent Consultant, providing start-ups and as well as mature organizations with advice in financial reporting, due diligence and business models (August 2011-August 2013), Chief Financial Officer at Answers Corporation (December 2002-July 2011) and Audit Manager at Coopers & Lybrand (currently PriceWaterhouse Coopers) in New York City (10 years). He holds a Bachelor of Business Administration degree. He is a Certified Public Accountant.

Arie Weber

Mr. Arie Weber has been appointed Director at Kitov Pharmaceuticals Holdings Ltd effective January 22, 2017. His work experience includes the following positions: Chairman at Inventech Investments Company Ltd, Aloni Meitar Ltd. and at Scorpio Investments (A.V.) Ltd. and Director at Lapidoth Heletz 2004 (Management) Ltd and at Scailex Corporation Ltd. He holds additional Directorship positions at various companies. Mr. Weber holds a Masters degree in Economics and Business Administration from Kharkov National University of Economics.

Alain Zeitoun

Dr. Alain Zeitoun serves as External Director at Kitov Pharmaceuticals Holdings Ltd since December 16, 2013. His work experience includes the role of Chief Executive Officer and Business Consultant at Chi2Gel Ltd. for six years and Independent Consultant for medical devices, biotechnology and pharma sector for seven years. He holds a Doctorate of Medicine degree in Medicine from ESCP Paris Business School and a Masters degree in Management from Paris XIII University.

Philip Serlin

Mr. Philip Adam Serlin serves as Independent Director at Kitov Pharmaceuticals Holdings Ltd since July 18, 2013. His work experience includes the following roles: Chief Financial Officer and Operations Manager at BioLine RX Ltd. He holds a Bachelors degree in Accounting from Yeshiva University and a MBA degree, majoring in Economics and Public Policy from George Washington University.

Revital Stern-Raff

Ms. Revital Stern-Raff has been appointed Independent Director at Kitov Pharmaceuticals Holdings Ltd effective March 2, 2017. Her work experience includes the following roles: Chief Financial Officer of several municipal development and community association units of the City of Giv'atayim, Israel, Comptroller and Economist at Ilex Medical Ltd (2006-2013) and Independent Director at Real Imaging Holdings Ltd (2009 and 2012). She holds a Bachelor of Business Administration degree, majoring in Finance, and a MBA degree, majoring in Finance, both from Hamichlala Leminhal. She is a Certified Public Accountant.